Showing results (61-70 of 715) with videos related to
Sort By:
Pageof 72
Cancer Journal (Sudbury, Mass.)|May 16, 2024
PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and TherapyJorge D Oldan, Frankis Almaguel, Andrew F Voter, et al.The Canadian Journal of Urology|February 13, 2023
Image acquisition and interpretation of 18F-DCFPyL (piflufolastat F 18) PET/CT: How we do itSteven P Rowe, Andrew F Voter, Rudolf A Werner, et al.Expert Review of Anticancer Therapy|May 23, 2022
Piflufolastat F-18 (18F-DCFPyL) for PSMA PET imaging in prostate cancerAndrew F Voter, Rudolf A Werner, Kenneth J Pienta, et al.Clinical Nuclear Medicine|August 15, 2017
An Unusual Case of Penile Prostate Cancer Uncovered by Multiparametric MRI and PSMA-Targeted 18F-DCFPyL PET/CTSteven P Rowe, Michael A Gorin, Linda C Chu, et al.Natural Product Reports|November 4, 2020
Triptolide: reflections on two decades of research and prospects for the futureLu Tong, Qunfei Zhao, Emmanuel Datan, et al.Oncotarget|July 21, 2016
[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinomaIl Minn, Soo Min Koo, Hye Soo Lee, et al.Frontiers in Oncology|September 26, 2024
Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinomaRajan Singh, Anand K Thotakura, Suresh Alati, et al.Clinical Nuclear Medicine|April 19, 2022
Rechallenge With Additional Doses of 177 Lu-DOTATOC After Failure of Maintenance Therapy With Cold Somatostatin AnalogsAlexander Weich, Rudolf A Werner, Sebastian E Serfling, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2015
Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane AntigenAna P Kiess, Il Minn, Ying Chen, et al.Tomography (Ann Arbor, Mich.)|January 26, 2016
Uptake of 18F-DCFPyL in Paget's Disease of Bone, an Important Potential Pitfall in Clinical Interpretation of PSMA PET StudiesSteven P Rowe, Curtiland Deville, Channing Paller, et al.Pageof 72